Search Results
Jul 27, 2026, 10:31 ET Food Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight
Tablet), InnoUp Farma (INP20), Allergy Therapeutics (VLP Peanut), Intrommune Therapeutics (INT301), Regeneron Pharmaceuticals (Linvoseltamab + Dupilumab), RAPT Therapeutics (RPT904), and several other innovators.LAS VEGAS, July
More news about: DelveInsight Business Research, LLP
Feb 16, 2026, 17:31 ET Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight
Kirin, UCB Biopharma, Arcutis Biotherapeutics, Vanda Pharmaceuticals, Kyowa Kirin, Sanofi, KeyMed Biosciences, Asana BioSciences, Bristol-Myers Squibb, RAPT Therapeutics, Allakos, Novartis, BioMimetix, Shanghai Hengrui Pharmaceutical Co, Connect Biopharma, Pfizer, Evommune, Inc., Fresh Tracks Therapeutics,
More news about: DelveInsight Business Research, LLP
Feb 11, 2026, 20:51 ET Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
RAPT Therapeutics, Inc. (NASDAQ: RAPT)'s sale to GSK plc for $58.00 per share. If you are a RAPT shareholder,
More news about: Halper Sadeh LLP
Feb 11, 2026, 20:02 ET Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
RAPT Therapeutics, Inc. (NASDAQ: RAPT)'s sale to GSK plc for $58.00 per share. If you are a RAPT shareholder,
More news about: Halper Sadeh LLP
Feb 06, 2026, 16:29 ET Halper Sadeh LLC is Investigating Whether NWE, DHIL, RAPT are Obtaining Fair Prices for its Shareholders
click here to learn more about your rights and options.RAPT Therapeutics, Inc. (NASDAQ: RAPT)'s sale to GSK plc for $58.00 per share. If you are a RAPT shareholder,
More news about: Halper Sadeh LLP
Feb 02, 2026, 15:30 ET $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger--JHG, FOLD, RAPT, and EXAS
you.RAPT Therapeutics, Inc. (NASDAQ: RAPT) related to its sale to
More news about: Monteverde & Associates PC
Jan 28, 2026, 18:41 ET Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights
click here to learn more about your rights and options.RAPT Therapeutics, Inc. (NASDAQ: RAPT)'s sale to GSK plc for $58.00 per share. If you are a RAPT shareholder,
More news about: Halper Sadeh LLP
Jan 28, 2026, 14:23 ET $HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA
you.RAPT Therapeutics, Inc. (NASDAQ: RAPT) related to its sale to GSK plc.
More news about: Monteverde & Associates PC
Jan 21, 2026, 00:40 ET Halper Sadeh LLC Encourages CVGW, RAPT, CFLT Shareholders to Contact the Firm to Discuss Their Rights
click here to learn more about your legal rights and options.RAPT Therapeutics, Inc. (NASDAQ: RAPT)'s sale to GSK plc for $58.00 per share. If you are a RAPT shareholder,
More news about: Halper Sadeh LLP
Jan 20, 2026, 14:34 ET $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RAPT Therapeutics, Inc. (NASDAQ: RAPT)
York City and is investigating RAPT Therapeutics, Inc. (NASDAQ: RAPT) related to its sale to GSK plc.
More news about: Monteverde & Associates PC
Jan 20, 2026, 12:15 ET Shareholder Alert: The Ademi Firm investigates whether RAPT Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders
transaction, RAPT stockholders can elect to receive $58.00 per share for an estimated aggregate equity value of $2.2 billion. RAPT insiders will receive substantial benefits as part of change of control arrangements.The transaction agreement unreasonably limits competing transactions for RAPT by imposing
More news about: Ademi LLP
Dec 10, 2025, 07:29 ET China Premiere of 'Avatar: Fire and Ash' Highlight of 7th HIIFF
China premiere of 'Avatar: Fire and Ash', with director James Cameron and several key members of the cast and crew making appearances that drew the rapt gaze of fans from around the world to the tropical beach city of Sanya.
More news about: Hainan International Media Center (HIMC)
Nov 19, 2025, 16:48 ET Rapt.AI & Massed Compute Introduce Autonomous AI Infrastructure Redefining the NeoCloud Era
infrastructure becomes autonomous," said Charlie Leeming, CEO of Rapt. "Rapt was built to give every enterprise the power to run AI at scale without the cost, complexity, or manual engineering effort that traditionally holds teams back. By bringing Rapt to Massed Compute, we're redefining what next-generation
More news about: Rapt.Ai
Oct 29, 2025, 08:30 ET Miami Biotech Collective Introduces Board of Advisors and Women's Leadership Council to Shape South Florida's Biotech Future
Marinus Therapeutics, has over 30 years in biotech and pharma, spanning clinical practice, investment leadership, and board service at atai Life Sciences, RAPT Therapeutics and Caribou Biosciences.
More news about: Miami Biotech Collective
Oct 13, 2025, 17:31 ET Allergic Rhino-Conjunctivitis Market Poised for Significant Growth in the Coming 10 Years Amid Increasing Therapeutic Advancements | DelveInsight
Allakos, Inc., Regeneron Pharmaceuticals, Marinomed Biotech AG, Eleusis Holdings Ltd, IACTA Pharmaceuticals, JW Pharmaceutical, Nanomerics, OKYO Pharma, RAPT Therapeutics, Allakos, Sylentis, Postbiotica, Stuart Therapeutics, Oyster Point Pharma, Bausch Health Companies Inc., Marinomed Biotech AG, ILTOO Pharma,
More news about: DelveInsight Business Research, LLP